openPR Logo
Press release

Urticaria Treatment Market To Witness an Exponentiation between 2020 and 2030

11-26-2020 08:04 PM CET | Health & Medicine

Press release from: Persistence Market Research

Urticaria affects around 15-25% of people at some point in their lives. The symptoms of the condition include itching followed by hives on any area of the body or the occurrence of bumps. It may be triggered by some food allergens, drug allergens, insect bites, bacterial/viral infection or any physical stimuli such as pressure, cold, heat, exercise or sun exposure. Acute urticaria incidence is higher in people with atopy, and the condition mostly develops in children and young adults. Chronic urticaria occurs as episodic or daily hives lasting for at least six weeks, thus impairing the quality of life. According to World Allergy Organization, up to 1.8% of the population is currently suffering from chronic urticaria. The main objective of the urticaria treatment is to control the severity of these lesions and reduce pain and itching. Urticaria is caused by the release of certain vasoactive substances such as bradykinin, histamine, prostaglandin D2, and leukotriene C4 from mast cells & basophils in the dermis which results in causing extravasation of plasma into the dermis, thus developing an urticarial lesion. The peak incidence of the disease occurs in the age of 20-40 years. The condition is extremely distressing and affects patient’s quality of life.

Urticaria treatment starts with the physical examination and observing medical history followed by various histopathological tests. It includes restricting the use of certain allergens as well as taking antihistamines and other medications which block the symptom producing substance release. A combination approach is usually adopted to lower down the disease symptoms but the best option for urticaria treatment is to remove the trigger with the consultation of a specialist.

For detailed insights on enhancing your product footprint, request for a Sample Report here https://www.persistencemarketresearch.com/samples/23107

Urticaria Treatment market: Drivers & Restraints

There exist several factors supporting the growth of urticaria treatment market such as the availability of generic medications, easy availability via all distribution channels, rising awareness for hypersensitivity and increasing clinical access to diverse geographical areas. There are very few developments for the novel drug formulations in urticaria treatment which however limits the market. Along with this, preference towards other treatment options such as naturopathy, homeopathy etc. also restricts the market growth for urticaria treatment.

Urticaria Treatment market: Segmentation

By Disease Type:

Acute Urticaria
Chronic Urticaria
To receive extensive list of important regions, ask for TOC here https://www.persistencemarketresearch.com/toc/23107

By Drug Type:

Antihistamines
Histamine (H-2) Blockers
Anti-inflammation Medications
Antidepressants
Monoclonal Antibodies
Immune-Suppressing Drugs
By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Drug Stores
Urticaria treatment mainly involves generic drugs such as anti-histamines or anti-inflammatory medications. There exists an opportunity for the market players to develop novel medications for the chronic urticaria treatment and thus replacing the conventional therapeutics for improving the quality of life such as the approval of Omalizumab in 2014 for chronic hives. Most of the clinical trial studies revolve around the chronic urticarial condition.

Geographically, the market for Urticaria Treatment can be segmented into five regions – North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America dominates the global Urticaria treatment market owing to the robust healthcare infrastructure, easy access to healthcare facilities as well as companies in these regions also focus on the development of novel formulations for chronic urticaria treatment. This is followed by the European market because of high awareness about the disease and people focusing on improving the quality of life. Asia-Pacific is expected to have a significant growth rate during the forecast period owing to the improving access to healthcare facilities as well as increasing healthcare expenditure in the region. Latin America followed by MEA is expected to have comparatively less market share for urticaria treatment during the forecast period but the growth rate is expected to increase with significant developments being done to improve the healthcare facilities in the region.

Some of the players in the Urticaria Treatment market includes Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Genentech USA, Inc., Novartis Pharmaceuticals Corporation, McNeil Consumer Pharmaceuticals Co., Pernix Therapeutics, Merck & Co., Inc. and others.

For in-depth competitive analysis, Check Pre-Book here https://www.persistencemarketresearch.com/checkout/23107

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
U.S.A - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com

Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PersistenceMarketResearch.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urticaria Treatment Market To Witness an Exponentiation between 2020 and 2030 here

News-ID: 2196982 • Views: 281

More Releases from Persistence Market Research

Plantbased Protein Market to Witness Rise in Revenues During the Period 2019 - 2 …
Persistence Market Research has published a report on the plant-based protein market, which includes the global industry analysis for 2014-2018 and opportunity assessment for 2019-2029, and projects that the global plant-based protein market is expected to reach ~ US$ 9.6 Bn by the end of 2019 in terms of value, and is forecasted to reach ~ US$ 17.3 Bn by the end of 2029. According to the report, proteins are
The Chained Consumer Foodservice Market To Grasp Through The Fine Courses Of Nov …
The latest study by Persistence Market Research opines that the global chained consumer foodservice market is more popular than ever with paradigm changes in the way guests are eating and receiving their food. The chained consumer foodservice service market is expected to grow by around 4% over the forecast years, producing over US$ 280 Bn of incremental value from 2019 to 2027. This is partly driven by technology and mobile
New Product Launches To Put The Natural Organic Personal Care Product Market In …
The global natural and organic personal care products market was valued at ~US$ 10 Bn in 2014, which is estimated to reach ~US$ 14 Bn by the end of 2019. The natural and organic personal care products market is projected to expand at a robust CAGR during the next decade. Persistence Market Research (PMR) recently released a new market research on the natural and organic personal care products market covering
The Digestive Remedies Market To Ride On The Curve Of Innovation
According to a recently published PMR report, global digestive remedies market in 2018 exceeded US$ 15 Bn and is expected to grow at a moderate CAGR during the forecast period. Digestive remedies such as probiotics are used for therapy of gastrointestinal (GI) illnesses. The most prevalent digestive disorders include indigestion, heartburn, diarrhea, irritable bowel syndrome (IBS), movement disease, pediatric digestive illnesses, and constipation. To remain ‘ahead’ of your competitors, request

All 5 Releases


More Releases for Urticaria

Global Urticaria Drugs Market Research Methodology 2019: Business Plans, Inventi …
MarketResearchReports.Biz announces addition of new report "Urticaria Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026" to its database. Urticaria is a disease characterized by the development of hives, angioedema (swelling), or both at once. It affects about 20% of people at some point in their lives. Angioedema is a form of urticaria in which swelling is caused by edema in deeper dermal, cutaneous, and
Global Chronic Urticaria Or Hives Drug Market Anticipated for Progressive CAGR G …
The market for Chronic Urticaria Or Hives is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled “Title” which offer details about the current trends and analysis, as well as scope for the near future. This research study also covers information about the production, consumption and market share based on different active regions. Furthermore, an anticipated growth at a double-digit
Chronic Urticaria Or Hives Drug Sales Market Size, Share, Growth, Segmentation a …
In this report, the global Chronic Urticaria Or Hives Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Chronic Urticaria Or Hives Drug for these
Chronic Urticaria Or Hives - Pipeline Review, H2 2017 Published by MarketResearc …
“The Report Chronic Urticaria Or Hives - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz” Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Urticaria Or Hives - Pipeline Review, H2 2017, provides an overview of the Chronic Urticaria Or Hives (Dermatology) pipeline landscape. Chronic urticaria also known as hives, are an outbreak of swollen, pale red
Chronic Urticaria Or Hives - Pipeline Research and Markets Insight, 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Urticaria Or Hives - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Chronic Urticaria Or Hives. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265431 The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Chronic Urticaria
Global Analysis For Chronic Urticaria Or Hives Clinical Trials Review, H1, 2016
"The Report Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2016 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Summary GlobalData's clinical trial report, Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Urticaria Or Hives clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Urticaria Or Hives.